Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions (Q40091895)

17 September 2017

1 reference

title

Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions (English)

1 reference

17 September 2017

Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

12 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

12 August 2023

author name string

M. J. Kendall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6138787

12 August 2023

L. Beeley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6138787

12 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6138787

12 August 2023

publication date

1 January 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0163725883900608?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

https://api.elsevier.com/content/article/PII:0163725883900608?httpAccept=text/plain

12 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Pharmacology & Therapeutics

12 August 2023

published in

1 reference

17 September 2017

volume

21

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

351-369

1 reference

Coronary artery syndromes after sudden propranolol withdrawal

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue

12 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Limitation of Work Performance in Normal Adult Males in the Presence of Beta-Adrenergic Blockade

12 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Rapid clonidine withdrawal with blood pressure overshoot exaggerated by beta-blockade

12 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Myometrial and cardiovascular effects of an adrenergic blocking drug in human pregnancy

12 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol in human plasma and breast milk

12 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Sleep disturbances, nightmares and other possible central nervous disturbances in a population sample of women, with special reference to those on antihypertensive drugs

12 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Effect of rifampicin on metoprolol and antipyrine kinetics

12 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol

12 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol and hydrallazine in the management of essential hypertension in pregnancy

12 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Hypersensitivity to Adrenergic Stimulation after Propranolol Withdrawal in Normal Subjects

12 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol)

12 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Treatment of thyrotoxicosis during pregnancy with propranolol

12 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Change in symptoms of hypertensive patients after referral to hospital clinic

12 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

beta-Adrenoceptor blockers, plasma-potassium, and exercise

12 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

The Psoriasiform Eruption Induced by Practolol

12 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Contribution of 4-hydroxy-alprenolol to adrenergic beta receptor blockade of alprenolol

12 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

12 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Comparison of atenolol and propranolol during insulin-induced hypoglycaemia

12 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Nadolol in human serum and breast milk

12 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists

12 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Objective Measurement of Performance during Acute Stress in Patients with Essential Hypertension: Assessment of the Effects of Propranolol and Metoprolol

12 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Self-poisoning with beta-blockers

12 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol for the treatment of hypertension in pregnancy

12 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers

12 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.

12 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Letter: Skin reactions to practolol.

12 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Cutaneous and ocular reactions to practolol.

12 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Letter: Propranolol and pregnancy.

12 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Impotence, Smoking, and β-Blocking Drugs

12 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral Propranolol

12 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management

12 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blocker

12 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Influence of alprenolol on hemodynamic and metabolic responses to prolonged exercise in subjects with hypertension

12 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy

12 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol in patients with angina pectoris.

12 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol administration during pregnancy: effects on the fetus

12 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Elevated beta-adrenergic receptor number after chronic propranolol treatment

12 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol and hypoglycemia: the effects of beta-adrenergic blockade on glucose and alanine levels during fasting.

12 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Lidocaine-propranolol interactions.

12 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Effects on the neonate of propranolol administered during pregnancy

12 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Influence of pentobarbital on metoprolol plasma levels

12 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

12 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions

12 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Editorial: Discontinuation of propranolol therapy. Cause of rebound angina pectoris and acute coronary events

12 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol

12 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Severe hypoglycaemia during physical exercise and treatment with beta-blockers.

12 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Adverse effects of antihypertensive drugs

12 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Hemodynamic and electrophysiologic interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide

12 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: Metoprolol, nadolol, and acebutolol

12 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise

12 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

A single and multiple dose pharmacokinetic and pharmacodynamic comparison of conventional and slow-release metroprolol

12 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Are selective beta-adrenoceptor blocking drugs an advantage?

12 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

12 August 2023

Women in new drug trials

65

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Metoprolol pharmacokinetics and the oral contraceptive pill

12 August 2023

66

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Interaction of cimetidine with metoprolol, propranolol, or atenolol

12 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Effects of short-term and long-term treatment with cardio-selective and non-selective beta-receptor blockade on carbohydrate and lipid metabolism and on plasma catecholamines at rest and during exercise

12 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol withdrawal and thyroid hormones in patients with essential hypertension

12 August 2023

69

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Beta-blocker withdrawal syndrome?

12 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics

12 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Differentiation of Receptor Systems activated by Sympathomimetic Amines

12 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension

12 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Accumulation of atenolol and metoprolol in human breast milk

12 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris

12 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Modification by propranolol of cardiovascular effects of induced hypoglycaemia

12 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Beta Adrenergic Dilator Component of the Sympathetic Vascular Response in Skeletal MuscleInfluence on the micro-circulation and on transcapillary exchange

12 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade

12 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Interaction between oral propranolol and hydralazine

12 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

EFFECT OF A β-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS

12 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Effect of propranolol on ventilatory function

12 August 2023

84

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Effects of propranolol and metoprolol on the peripheral circulation

12 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Changes in blood pressure, heart rate, and plasma noradrenaline concentration after sudden withdrawal of propranolol

12 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Raynaud's phenomenon as side effect of beta-blockers in hypertension

12 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

12 August 2023

Practolol peritonitis

89

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Beta-blocker withdrawal syndrome?

12 August 2023

91

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

12 August 2023

92

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

12 August 2023

93

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Comparison of beta adrenergic receptor subtypes in mammalian tissues

12 August 2023

94

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Acute coronary syndromes following abrupt cessation of oral propranolol therapy

12 August 2023

96

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Mechanism of propranolol withdrawal phenomena

12 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Beta-adrenoceptor blockers and the blood-brian barrier

12 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Sotalol, prolonged Q-Tc interval, and tachyarrhythmias

12 August 2023

99

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Comparison of propranolol, metoprolol, and acebutolol on insulin-induced hypoglycaemia

12 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Management of pregnancy in patients with hypertrophic cardiomyopathy

12 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol.

12 August 2023

102

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Sotalol as a hypotensive agent in pregnancy

12 August 2023

103

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

CARCINOGENIC ACTION OF PRONETHALOL.

12 August 2023

104

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Central actions of β-adrenoceptor blocking drugs in man

12 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

The effect of beta-adrenoceptor blockade on factors affecting exercise tolerance in normal man

12 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients

12 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Long-term propranolol therapy in pregnancy: Maternal and fetal outcome

12 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Systemic lupus erythematosus syndrome induced by practolol.

12 August 2023

110

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Pathology of practolol-induced ocular toxicity

12 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Metoprolol withdrawal phenomena: mechanism and prevention

12 August 2023

112

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Pathogenesis of Adverse Drug Reactions

12 August 2023

113

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a review

12 August 2023

114

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Self-poisoning with beta-blockers.

12 August 2023

116

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Intermittent claudication complicating beta-blockade

12 August 2023

117

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Adrenergic Modulation of Extrarenal Potassium Disposal

12 August 2023

118

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Adrenergic hypersensitivity after beta-blocker withdrawal

12 August 2023

119

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Prolonged curarization associated with propranolol

12 August 2023

120

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Current concepts: beta-blockers in pregnancy

12 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients

12 August 2023

122

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy

12 August 2023

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Plasma propranolol concentrations and the erythrocyte sedimentation rate

12 August 2023

124

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol

12 August 2023

125

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol withdrawal syndrome - why?

12 August 2023

127

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Review of review Partial agonist activity of beta-adrenoceptor blocking drugs

12 August 2023

128

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Comparison of effects of propranolol and metoprolol on airways obstruction in chronic bronchitis

12 August 2023

129

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction

12 August 2023

130

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Withdrawal of propranolol and myocardial infarction

12 August 2023

131

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Proximal myopathy during beta-blockade

12 August 2023

133

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Anti-hypertensive therapy with propranolol during pregnancy and lactation

12 August 2023

134

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Atenolol in the treatment of pregnancy‐induced hypertension

12 August 2023

137

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans

12 August 2023

138

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Inhibition of propranolol metabolism by chlorpromazine

12 August 2023

139

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Metabolic effects of beta-adrenoreceptor blockers

12 August 2023

140

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.

12 August 2023

141

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Trasicor in Angina Pectoris: a Double-blind Trial

12 August 2023

142

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Elevated plasma free drug concentrations of propranolol and diazepam during cardiac catheterization.

12 August 2023

143

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Exercise responses of healthy subjects in the evaluation of cardioselectivity of?-blockers

12 August 2023

144

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus

12 August 2023

145

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Letter: Skin reactions to practolol

12 August 2023

146

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Untoward effects associated with practolol administration: oculomucocutaneous syndrome

12 August 2023

147

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

Propranolol in the control of schizophrenic symptoms

12 August 2023

148

1 reference

https://api.crossref.org/works/10.1016/0163-7258(83)90060-8

12 August 2023

Identifiers

1 reference

17 September 2017

1 reference